This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Coronary Heart Disease or Coagulation Disorder
and you are
between 18 and 28
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

In this 94 healthy subjects Phase I clinical trial, we assess the clinical profile of Anfibatide, a specific glycoprotein Ib antagonist. This study represents the first clinical evidence that Anfibatide exhibits strong anti-platelet effects, excellent reversibility, and low bleeding potential in healthy human subjects.

Provided treatments

  • Drug: Anfibatide

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01588132. The sponsor of the trial is Lee's Pharmaceutical Limited and it is looking for 94 volunteers for the current phase.
Official trial title:
First Assessment of the Glycoprotein Ib-IV-V Complex Antagonist Anfibatide in Healthy Human Volunteers